Cardiol Therapeutics Inc. (CRDL) is looking to harness the proven anti-inflammatory properties of cannabidiol (CBD) to help reverse deadly inflammatory processes that occur in heart disease with its flagship drug, CardiolRx...

You must be a subscriber to view this content. Learn more about NICI Membership here.

Sign In

Enter your details below.